Time-Cap Labs recalled over manufacturing violations
- Recall date
- October 2, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Marksans Pharma Limited recalls Time-Cap Labs, Inc. Metformin Hydrochloride Extended Release Tablets USP 750 mg, 100 count bottles, Rx Only Manufacture…
- Recall number
- D-0062-2021
- FDA classification
- Class II
- Brand / firm
- Marksans Pharma Limited
- Sold / distributed
- Nationwide
Why it was recalled
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Time-Cap Labs, Inc. Metformin Hydrochloride Extended Release Tablets USP 750 mg, 100 count bottles, Rx Only Manufactured for: Time-Cap Labs, Inc. 7 Michael Avenue Farmingdale, NY 11735, USA Manufactured by: Marksans Pharma Ltd. Plot No. L-82, L-83, Verna Indl. Estate. Verna Goa-403 722 India NDC 49483-624-01
Get recall alerts
Free email alert whenever Marksans Pharma Limited has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Marksans Pharma Limited